慢性鼻窦炎中CRS-PRO与SNOT-22和2型炎症介质的相关性
研究评估123例慢性鼻窦炎患者(71例无鼻息肉,52例伴鼻息肉)在内镜鼻窦手术前后,SNOT-22与CRS-PRO两种患者报告结局指标与2型生物标志物的相关性,发现术后CRS-PRO总分与2型生物标志物显著相关,尤其在伴鼻息肉患者中。
要点
- 术前SNOT-22和CRS-PRO与任何生物标志物均无显著相关。
- 术后CRS-PRO与IL-5和IL-13相关(p=0.012和0.003),SNOT-22与任何生物标志物均不相关。
- 伴鼻息肉患者术后CRS-PRO与IL-5、IL-13和ECP相关,SNOT-22与IL-5和IL-13相关。
核心结论
- CRS-PRO总分与2型生物标志物显著相关,尤其在术后评估和伴鼻息肉患者中。
研究设计与样本
- 收集123例慢性鼻窦炎患者(71例无鼻息肉,52例伴鼻息肉)中鼻道黏液,并在内镜鼻窦手术前和术后6至12个月填写SNOT-22和CRS-PRO。
- 使用多重微珠法和酶联免疫吸附试验测量IL-4、IL-5、IL-13和嗜酸性阳离子蛋白(ECP)。
主要发现
- 术前SNOT-22和CRS-PRO与任何生物标志物均无显著相关。
- 术后CRS-PRO与IL-5和IL-13相关(p=0.012和0.003),SNOT-22与任何生物标志物均无显著相关。
- 伴鼻息肉患者术前CRS-PRO和SNOT-22均与IL-4相关(两者p=0.04)。
- 伴鼻息肉患者术后CRS-PRO与IL-5、IL-13和ECP相关(p=0.02、0.024和0.04),SNOT-22与IL-5和IL-13相关(p=0.038和0.02)。
- 无鼻息肉患者术前术后任何2型生物标志物均无显著关系。
关键数值与推荐
- 探索性分析显示SNOT-22鼻科亚域和CRS-PRO鼻心理亚域与2型生物标志物相关性更好。
- 单项分析中,术后IL-13与CRS-PRO的12项中8项显著相关,而SNOT-22的22项中6项显著相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The 22-item Sino-Nasal Outcome Test (SNOT-22) and 12-item Patient Reported Outcomes in Chronic Rhinosinusitis (CRS-PRO) instrument are validated patient-reported outcomes measures in CRS. In this study we assess the correlation of these with type 2 (T2) biomarkers before and after endoscopic sinus surgery (ESS). METHODS: Middle meatal mucus data were collected and the SNOT-22 and CRS-PRO were administered to 123 patients (71 CRS without nasal polyps [CRSsNP], 52 CRS with nasal polyps [CRSwNP]) with CRS before and 6 to 12 months after undergoing ESS. Interleukin (IL)-4, IL-5, IL-13, and eosinophilic cationic protein (ECP) were measured using a multiplexed bead assay and enzyme-linked immunoassay. Pre- and post-ESS SNOT-22 and CRS-PRO were compared with T2 biomarkers. RESULTS: Before ESS neither PROM correlated with any biomarker. After ESS, CRS-PRO showed a correlation with 2 mediators (IL-5 and IL-13: p = 0.012 and 0.003, respectively) compared with none for the SNOT-22. For CRSwNP patients, pre-ESS CRS-PRO and SNOT-22 correlated with IL-4 (p = 0.04 for both). However, after ESS, CRS-PRO correlated with 3 biomarkers (IL-5, IL-13, and ECP: p = 0.02, 0.024, and 0.04, respectively) and SNOT-22 with 2 biomarkers (IL-5 and IL-13: p = 0.038 and 0.02, respectively). There were no significant relationships between any of the T2 biomarkers pre- or post-ESS among patients with CRSsNP. Exploratory analyses of the subdomains showed the SNOT-22 rhinologic and CRS-PRO rhinopsychologic subdomains correlated better with the T2 biomarkers. On individual item analysis, IL-13 correlated significantly post-ESS with 8 of 12 items on the CRS-PRO vs 6 of 22 items on the SNOT-22. CONCLUSION: The CRS-PRO total score showed a significant correlation with T2 biomarkers especially when assessed post-ESS and among CRSwNP patients.
引用
- Racette SD, Schneider AL, Ganesh M, et al. CRS-PRO and SNOT-22 correlations with type 2 inflammatory mediators in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2022. PMID: 35363947. doi:10.1002/alr.23002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。